ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Qualitative Research"

  • Abstract Number: 1699 • ACR Convergence 2020

    Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies

    Iman Qaiser1, Tracy Koehler1 and Richard Martin2, 1Mercy Health Saint Mary's, Grand Rapids, MI, 2Michigan State University College of Human Medicine, Grand Rapids, MI

    Background/Purpose: In many hospitals residents are the first providers to evaluate new patients. Consequently, residents often initiate the work-up of newly admitted patients. Multiple studies…
  • Abstract Number: 0152 • ACR Convergence 2020

    Veterans with RA and Gout Identify Their Goals and How They Can Work with Clinicians to Achieve Their Goals

    Swathi Reddy1, Aricca Van Citters2, Rashmi Arora1, Kyawt Shwin1, Lisa Johnson2, Jabeen Ahmad2, Guy Eakin3, Eugene Nelson2, Andreas Reimold1 and Salahuddin Kazi1, 1Veterans Affairs North Texas Healthcare System / UT Southwestern Medical Center, Dallas, TX, 2The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, 3Arthritis Foundation, Atlanta, GA

    Background/Purpose: Understanding patient goals and concerns is essential for aligning treatment decisions with patient preferences and supporting effective patient-clinician partnerships. Yet, little is known about…
  • Abstract Number: 1710 • ACR Convergence 2020

    Remote Rheumapalooza: Reboot of a Foundational Rheumatology Curriculum for Pre-Clinical Medical Students in the Era of Virtual Learning

    Kristen Hayward1, Meghan Kiefer2 and Helen Emery3, 1Seattle Children's Hospital, Seattle, WA, 2University of Washington School of Medicine, Seattle, WA, 3University of Washington, Seattle, WA

    Background/Purpose: The original Rheumapalooza course was a required, independent 12 hour curriculum for pre-clinical medical students in the UWSOM from 2010 - 20161,2. In 2015,…
  • Abstract Number: 0170 • ACR Convergence 2020

    Utilizing Design Thinking to Develop a Decision Aid for Patients with Psoriasis and Psoriatic Arthritis

    Marilyn Wan1, Michele Almonte2, Joel Gelfand1 and Alexis Ogdie2, 1University of Pennsylvania, Philadelphia, 2University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Given the complexity of available treatment recommendations, patients with psoriatic disease would benefit from a process fostering shared decision-making using a patient-centered approach. True…
  • Abstract Number: 1774 • ACR Convergence 2020

    Making Decisions About Medication Use, Pregnancy, and Having Children Among Women with Rheumatoid Arthritis: A Constructivist Grounded Theory Study

    Nevena Rebic1, Ria Garg2, Sarah Munro2, Glen Hazlewood3, Neda Amiri2, Nick Bansback2, Stephanie Ensworth2, Corisande Baldwin4, Laurie Proulx5 and Mary De Vera1, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of British Columbia, Calgary, AB, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada

    Background/Purpose: Despite guidelines for managing rheumatoid arthritis (RA) in pregnancy, high rates of discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) considered safe for women with RA…
  • Abstract Number: 0256 • ACR Convergence 2020

    Patient Perspective of the Type 1 and 2 SLE Model: A Qualitative Study

    Amanda Eudy1, Amy Corneli2, Kevin McKenna2, Mithu Maheswaranathan1, Bryce Reeve2, David Pisetsky3 and Megan Clowse4, 1Duke University, Durham, NC, 2Duke University, Durham, 3Duke University Medical Center, Durham, NC, 4Duke University, Chapel Hill, NC

    Background/Purpose: To better characterize the signs and symptoms of systemic lupus erythematosus (SLE) we have developed a conceptual model to characterize SLE activity into two dimensions: Type 1…
  • Abstract Number: 1784 • ACR Convergence 2020

    Roles and Perspectives of Partners of Women with Rheumatoid Arthritis on Reproductive Decision Making: A Constructivist Grounded Theory Study

    Ria Garg1, Nevena Rebic2, Neda Amiri1, Glen Hazlewood3, Corisande Baldwin4, Stephanie Ensworth1, Laurie Proulx5 and Mary De Vera2, 1University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of British Columbia, Calgary, AB, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada

    Background/Purpose: Partners of women with rheumatoid arthritis (RA) often take on caregiving roles given the debilitating nature of RA. No research to date has explored…
  • Abstract Number: 0436 • ACR Convergence 2020

    The Addressing Lupus Pillars for Health Advancement (ALPHA) Project: Establishing Consensus and Prioritization of Global Community Recommendations to Address Major Challenges in Lupus Diagnosis, Care, Treatment and Research

    Karin Tse1, Sanjyot Sangodkar2, Kathleen Arntsen3, Sang-Cheol Bae4, Lauren Bloch2, Ian Bruce5, Erin Connolly-Strong6, Karen Costenbader7, Thomas Dörner8, Sydney Evans9, Timothy Franson2, Kenneth Getz10, Amy Kao11, Kenneth Kalunian12, Bradley Dickerson13, Susan Manzi14, Eric Morand15, Yaritza Peña10, Sandra Raymond16, Brad Rovin17, Laura Schanberg18, Joan Von Feldt19, Victoria Werth20, Angel Williams21, David Zook2 and Leslie Hanrahan16, 1Lupus Foundation of America, DC, WA, 2Faegre Drinker Consulting, Washington, DC, 3Lupus and Allied Diseases Association, Inc., Verona, NY, 4Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 5Centre for Epidemiology Versus Arthritis, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, 6Mallinckrodt, Austin, TX, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8DRFZ and Charité University Hospitals, Berlin, Germany, 9Lupus Patient Representative, Riverdale, MD, 10Tufts Center for the Study of Drug Development, Boston, MA, 11EMD Serono (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, 12University of California San Diego, La Jolla, CA, 13Aurinia Pharmaceuticals, Fort Washington, PA, 14Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, PA, 15Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 16Lupus Foundation of America, Washington, DC, 17The Ohio State University, Columbus, 18Duke University Medical Center, Durham, NC, 19GlaxoSmithKline, WILMINGTON, DE, 20University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Philadelphia, PA, 21Lupus Patient Representative, Richmond, VA

    Background/Purpose: The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritize and address top barriers in lupus impacting…
  • Abstract Number: 1839 • ACR Convergence 2020

    Medication Adherence Barriers and Opportunities to Overcome Them Among Patients with SLE

    Lena Eder1, Megan Clowse2, Amanda Eudy3, Jennifer Rogers4, Rebecca Sadun3, Lisa Criscione-Schreiber5, Jayanth Doss3, Mithu Maheswaranathan6, Amy Corneli7, Hayden Bosworth6 and Kai Sun6, 1Duke University Hospital, Chapel Hill, NC, 2Duke University, Chapel Hill, NC, 3Duke University, Durham, NC, 4Duke University Hospital, Durham, DE, 5Division of Rheumatology and Clinical Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, 6Duke University Hospital, Durham, 7Duke University, Durham

    Background/Purpose: Medication non-adherence in SLE is as high as 80%, yet little is known about adherence barriers faced by patients or interventions that improve adherence…
  • Abstract Number: 0571 • ACR Convergence 2020

    Improving Care for Patients with Inflammatory Arthritis by Enabling Physical Therapists to Directly Refer to Rheumatologists: A Qualitative Study

    Debbie Ehrmann Feldman1, Tatiana Orozco1, Sasha Bernatsky2, François Desmeules1, Jean Légaré3, Kadija Perreault3, Andrews Kwabena Tawiah4, Linda Woodhouse5, Michel Zummer6 and Anne Hudon7, 1Université de Montréal, Montreal, QC, Canada, 2The Research Institute of the McGill University Health Centre, Montreal, ON, Canada, 3Université Laval, Québec, QC, Canada, 4University of Alberta, Edmonton, AB, Canada, 5Curtin University, Perth, Australia, 6CH Maisonneuve-Rosemont, Montreal, Canada, 7Université de Montréal, Montreal, Canada

    Background/Purpose: Early referral to rheumatology of persons with suspected inflammatory arthritis is associated with better outcomes. Typically, patients are first seen by a family physician…
  • Abstract Number: 1869 • ACR Convergence 2020

    “Rheum to Diagnosis”: Uncovering Impediments to Accurate Diagnosis of Non-radiographic Axial Spondylarthritis (nr-axSpA)

    Sonam Kiwalkar1, Atul Deodhar1 and Richard Howard2, 1Oregon Health & Science University, Portland, OR, 2Spondylitis Association of America, Van Nuys, CA

    Background/Purpose: In the US, there is up to a 14-year delay in axSpA diagnosis, which is likely greater for nr-axSpA.1 Impediments to timely diagnosis of…
  • Abstract Number: 0823 • ACR Convergence 2020

    Identifying Physician-Perceived Barriers to a Pragmatic Treatment Trial in Rheumatoid Arthritis

    Haiyan Qu1, Shamly Austin2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Gateway Health Plan®, Pittsburgh, PA

    Background/Purpose: The aim of this qualitative research was to identify physician-perceived patient and clinic barriers to patient recruitment in a RA pragmatic trial of anti-TNF…
  • Abstract Number: 1964 • ACR Convergence 2020

    Engaging Patients in the Development of a Quality Measure of Functional Status to Improve Care Among Patients with Rheumatoid Arthritis

    Sarah Hopkins Gillespie1, Liana Fraenkel2, Lisa Suter3, Gabriela Schmajuk4, Patricia Katz5, Alex Limanni6 and Alexis Ogdie1, 1University of Pennsylvania, Philadelphia, PA, 2Yale School of Medicine; West Haven VA; Berkshire Medical Center, Lenox, MA, 3Yale School of Medicine, New Haven, CT, 4University of California, San Francisco, Atherton, CA, 5University of California, San Francisco, Novato, CA, 6n/a, Dallas, TX

    Background/Purpose: The ACR Quality of Care committee is working to develop a quality measure to reflect functional assessment in rheumatoid arthritis (RA). One proposed approach…
  • Abstract Number: 1130 • ACR Convergence 2020

    Patient Perspectives on Biobanking and Data-linkage for Rheumatic Disease Research

    Abhishikta Dey1, Marita Cross2, Tom Lynch3, Carlos El-Haddad4 and Lyn March5, 1NSW Rheumatology Advanced Trainee, Sydney, New South Wales, Australia, 2Institute of Bone and Joint Research, University of Sydney, Sydney, Australia, 3A3BC, Sydney, New South Wales, Australia, 4Liverpool Hospital, Sydney, Australia, 5Institute of Bone and Joint Research, University of Sydney, Sydney, New South Wales, Australia

    Background/Purpose: The causes of arthritis and autoimmune conditions remain unknown. A complex interplay of genetic and environmental factors is thought to underlie these diseases. Prospective…
  • Abstract Number: 1967 • ACR Convergence 2020

    Combating Rheumatologist Burnout: Use of Protocol Driven Medication Refill by Pharmacists

    Eva Rottmann1, Jonida Cote2, Swana Thomas3, Dante Grassi1, Joseph Chronowski1, Lisa L. Schroeder1, David Pugliese4 and Eric Newman1, 1Geisinger Medical Center, Danville, PA, 2Geisinger Medical Center, Danvile, PA, 3Geisinger Medical Center, Wilkes-Barre, PA, 4Geisinger Health System, Wilkes Barre, PA

    Background/Purpose: Increased electronic health record (EHR) administrative workload is a great source of physician dissatisfaction. We embedded pharmacists into our Rheumatology team in 2019. This…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology